Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Compounded semaglutide typically arrives in multi-dose vials
Identified by CAS Number 2381089-83-2, Retatrutide is widely referenced in metabolic and obesity research literature as the first characterized triple agonist targeting the GIP receptor, GLP-1 receptor, and glucagon receptor (GCGR) simultaneously within a single molecular scaffold
Youre allergic to semaglutide or any of its ingredients
Use of GLP-1RA is protective and prevents bone fractures over a longer period of use in T2DM patients in a recent trial in 2020 liraglutide showed to have decreased bone resorption compared to placebo (120)
Glucagon-like peptide-1, glucose homeostasis and diabetes
Your individual response timeline might differ by several weeks in either direction
US$ 20.43
US$ 23.81
US$ 24.50
US$ 23.12
US$ 27.62
